
Can Targacept Beat Aricept?
Targacept is taking a confident approach in its latest clinical trial. Rather than pitting their new Alzheimer’s drug against a placebo, they are putting it
Targacept is taking a confident approach in its latest clinical trial. Rather than pitting their new Alzheimer’s drug against a placebo, they are putting it
VIDEO & ARTICLE Bexarotene is an FDA-approved anti-cancer drug available under the brand name Targretin®. It clears Alzheimer’s biomarkers in mice like a charm. See
50,000 volunteers (with and without Alzheimer’s) are needed to participate in hundreds of clinical trials. People with Alzheimer’s, their families, and those who serve them
In 2012, Envivo’s experimental Alzheimer’s drugs improved cognitive function as the company won a Fierce BioTech Award. Learn about and participate in their newest Phase-2
Merck announced it is enrolling volunteers for the EPOCH clinical trial. Read details on their highly promising MK-8931 treatment for mild-to-moderate Alzheimer’s disease. Find out
VIDEO & ARTICLE Solanezumab slowed Alzheimer’s by 30% in a trial earlier this year. Find out what it’s maker, Ely Lilly, plans for the next step.
VIDEO & ARTICLE In trials, the most effective Alzheimer’s treatment so far is IVIG. At $50,000 per year, learn how scientists hope to bring down
VIDEO Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’
BOOK OF THE WEEK: Thoughtful Dementia Care is today’s best book on understanding the dementia experience. An easy-to-read, sensitive portrayal of managing the world of dementia.
Don Hayen is a retired doctor, diagnosed with Alzheimer’s at 71. But that diagnosis took way too long. Find out how his “cognitive reserve” fooled his doctors. See why he sure wished it hadn’t.
There is more to us than our brains and our bodies, says dementia expert Teepa Snow. “There’s more to us than that … When we’re together, we become more.” Watch now.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.